CAS RN: 866135-83-3
6-BROMO-8-METHYLIMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260323
250mg / 1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 866135-83-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
866135-83-3 / 6-bromo-8-methylimidazo[1,2-a]pyridine-2-carboxylic acid
Standard CAS: 866135-83-3
Multi CAS: No
Basic Information
copy
CAS
866135-83-3 copy
Multi CAS
No copy
Molecular Formula
BC9H7O2Rn2 copy
Molecular Weight
255.070000 copy
Exact Mass
253.969090 copy
InChI
InChI=1S/C9H7BrN2O2/c1-5-2-6(10)3-12-4-7(9(13)14)11-8(5)12/h2-4H,1H3,(H,13,14) copy
InChIKey
WFFIWTWLWKGLPB-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.11 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
54.59 copy
TPSA
54.6 copy
LogP / Solubility
WLOGP
2.1 copy
MLOGP
1.86 copy
XLogP3
2.7 copy
Consensus LogP
2.22 copy
Log S (ESOL)
-3.16 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.17 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.18 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.78 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy